Market Research Life Sciences Market Research Pharmaceuticals Market Research Drug Discovery Market Research

Metabolomics Market (Product and Service Type: Metabolomic Instruments, and Bioinformatics Tools and Services; and Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, and Others) - Global Industry An

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 237 Pages Transparency Market Research Pvt. Ltd. June, 2024 TNPR19060502
Best Price Guarantee
Price from $5,795
Length 237 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date June, 2024
SKU TNPR19060502

Metabolomics Market (Product and Service Type: Metabolomic Instruments, and Bioinformatics Tools and Services; and Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Metabolomics Market – Scope of Report

TMR’s report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global metabolomics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metabolomics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the metabolomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global metabolomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global metabolomics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global metabolomics market.

The report delves into the competitive landscape of the global metabolomics market. Key players operating in the global metabolomics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global metabolomics market profiled in this report.

Key Questions Answered in Global metabolomics Market Report
  • What is the sales/revenue generated by metabolomics across all regions during the forecast period?
  • What are the opportunities in the global metabolomics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Metabolomics Market – Research Objectives and Research Approach

The comprehensive report on the global metabolomics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global metabolomics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global metabolomics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metabolomics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metabolomics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Recent Advancements in Metabolomics Industry
5.2. Patent Analysis
5.3. Regulatory Landscape for Venous Stents in Key Regions / Countries
5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
5.5. Impact of COVID-19 Pandemic
6. Global Metabolomics Market Analysis and Forecasts, By Product and Service Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product and Service Type, 2020-2034
6.3.1. Metabolomics Instruments
6.3.1.1. Separation Tools
6.3.1.1.1. High Performance Liquid Chromatography
6.3.1.1.2. Gas Chromatography
6.3.1.1.3. Ultra Performance Liquid Chromatography
6.3.1.1.4. Capillary Electrophoresis
6.3.1.2. Detection Tools
6.3.1.2.1. Mass Spectrometry
6.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
6.3.1.2.3. Surface-based Mass Analysis
6.3.2. Bioinformatics Tools and Services
6.3.2.1. Bioinformatics Services
6.3.2.2. Bioinformatics Tools and Databases
6.4. Market Attractiveness By Product and Service Type
7. Global Metabolomics Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Biomarker Discovery
7.3.2. Drug Discovery
7.3.3. Toxicology Testing
7.3.4. Nutrigenomics
7.3.5. Personalized Medicine
7.3.6. Others
7.4. Market Attractiveness By Application
8. Global Metabolomics Market Analysis and Forecasts, By Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Indication, 2020-2034
8.3.1. Oncological Disorders
8.3.2. Cardiovascular Disorders
8.3.3. Neurological Disorders
8.3.4. Metabolic Disorders
8.3.5. Others
8.4. Market Attractiveness By Indication
9. Global Metabolomics Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Academic and Research Institutes
9.3.2. Pharmaceutical and Biotechnology Companies
9.3.3. Contract Research Organizations
9.4. Market Attractiveness By End-user
10. Global Metabolomics Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Metabolomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product and Service Type, 2020-2034
11.2.1. Metabolomics Instruments
11.2.1.1. Separation Tools
11.2.1.1.1. High Performance Liquid Chromatography
11.2.1.1.2. Gas Chromatography
11.2.1.1.3. Ultra Performance Liquid Chromatography
11.2.1.1.4. Capillary Electrophoresis
11.2.1.2. Detection Tools
11.2.1.2.1. Mass Spectrometry
11.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
11.2.1.2.3. Surface-based Mass Analysis
11.2.2. Bioinformatics Tools and Services
11.2.2.1. Bioinformatics Services
11.2.2.2. Bioinformatics Tools and Databases
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Biomarker Discovery
11.3.2. Drug Discovery
11.3.3. Toxicology Testing
11.3.4. Nutrigenomics
11.3.5. Personalized Medicine
11.3.6. Others
11.4. Market Value Forecast By Indication, 2020-2034
11.4.1. Oncological Disorders
11.4.2. Cardiovascular Disorders
11.4.3. Neurological Disorders
11.4.4. Metabolic Disorders
11.4.5. Others
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Academic and Research Institutes
11.5.2. Pharmaceutical and Biotechnology Companies
11.5.3. Contract Research Organizations
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product and Service Type
11.7.2. By Application
11.7.3. By Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Metabolomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product and Service Type, 2020-2034
12.2.1. Metabolomics Instruments
12.2.1.1. Separation Tools
12.2.1.1.1. High Performance Liquid Chromatography
12.2.1.1.2. Gas Chromatography
12.2.1.1.3. Ultra Performance Liquid Chromatography
12.2.1.1.4. Capillary Electrophoresis
12.2.1.2. Detection Tools
12.2.1.2.1. Mass Spectrometry
12.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
12.2.1.2.3. Surface-based Mass Analysis
12.2.2. Bioinformatics Tools and Services
12.2.2.1. Bioinformatics Services
12.2.2.2. Bioinformatics Tools and Databases
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Biomarker Discovery
12.3.2. Drug Discovery
12.3.3. Toxicology Testing
12.3.4. Nutrigenomics
12.3.5. Personalized Medicine
12.3.6. Others
12.4. Market Value Forecast By Indication, 2020-2034
12.4.1. Oncological Disorders
12.4.2. Cardiovascular Disorders
12.4.3. Neurological Disorders
12.4.4. Metabolic Disorders
12.4.5. Others
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Academic and Research Institutes
12.5.2. Pharmaceutical and Biotechnology Companies
12.5.3. Contract Research Organizations
12.6. Market Value Forecast By Country / Sub-region, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product and Service Type
12.7.2. By Application
12.7.3. By Indication
12.7.4. By End-user
12.7.5. By Country / Sub-region
13. Asia Pacific Metabolomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product and Service Type, 2020-2034
13.2.1. Metabolomics Instruments
13.2.1.1. Separation Tools
13.2.1.1.1. High Performance Liquid Chromatography
13.2.1.1.2. Gas Chromatography
13.2.1.1.3. Ultra Performance Liquid Chromatography
13.2.1.1.4. Capillary Electrophoresis
13.2.1.2. Detection Tools
13.2.1.2.1. Mass Spectrometry
13.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
13.2.1.2.3. Surface-based Mass Analysis
13.2.2. Bioinformatics Tools and Services
13.2.2.1. Bioinformatics Services
13.2.2.2. Bioinformatics Tools and Databases
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Biomarker Discovery
13.3.2. Drug Discovery
13.3.3. Toxicology Testing
13.3.4. Nutrigenomics
13.3.5. Personalized Medicine
13.3.6. Others
13.4. Market Value Forecast By Indication, 2020-2034
13.4.1. Oncological Disorders
13.4.2. Cardiovascular Disorders
13.4.3. Neurological Disorders
13.4.4. Metabolic Disorders
13.4.5. Others
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Academic and Research Institutes
13.5.2. Pharmaceutical and Biotechnology Companies
13.5.3. Contract Research Organizations
13.6. Market Value Forecast By Country / Sub-region, 2020-2034
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product and Service Type
13.7.2. By Application
13.7.3. By Indication
13.7.4. By End-user
13.7.5. By Country / Sub-region
14. Latin America Metabolomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product and Service Type, 2020-2034
14.2.1. Metabolomics Instruments
14.2.1.1. Separation Tools
14.2.1.1.1. High Performance Liquid Chromatography
14.2.1.1.2. Gas Chromatography
14.2.1.1.3. Ultra Performance Liquid Chromatography
14.2.1.1.4. Capillary Electrophoresis
14.2.1.2. Detection Tools
14.2.1.2.1. Mass Spectrometry
14.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
14.2.1.2.3. Surface-based Mass Analysis
14.2.2. Bioinformatics Tools and Services
14.2.2.1. Bioinformatics Services
14.2.2.2. Bioinformatics Tools and Databases
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Biomarker Discovery
14.3.2. Drug Discovery
14.3.3. Toxicology Testing
14.3.4. Nutrigenomics
14.3.5. Personalized Medicine
14.3.6. Others
14.4. Market Value Forecast By Indication, 2020-2034
14.4.1. Oncological Disorders
14.4.2. Cardiovascular Disorders
14.4.3. Neurological Disorders
14.4.4. Metabolic Disorders
14.4.5. Others
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Academic and Research Institutes
14.5.2. Pharmaceutical and Biotechnology Companies
14.5.3. Contract Research Organizations
14.6. Market Value Forecast By Country / Sub-region, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product and Service Type
14.7.2. By Application
14.7.3. By Indication
14.7.4. By End-user
14.7.5. By Country / Sub-region
15. Middle East & Africa Metabolomics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product and Service Type, 2020-2034
15.2.1. Metabolomics Instruments
15.2.1.1. Separation Tools
15.2.1.1.1. High Performance Liquid Chromatography
15.2.1.1.2. Gas Chromatography
15.2.1.1.3. Ultra Performance Liquid Chromatography
15.2.1.1.4. Capillary Electrophoresis
15.2.1.2. Detection Tools
15.2.1.2.1. Mass Spectrometry
15.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
15.2.1.2.3. Surface-based Mass Analysis
15.2.2. Bioinformatics Tools and Services
15.2.2.1. Bioinformatics Services
15.2.2.2. Bioinformatics Tools and Databases
15.3. Market Value Forecast By Application, 2020-2034
15.3.1. Biomarker Discovery
15.3.2. Drug Discovery
15.3.3. Toxicology Testing
15.3.4. Nutrigenomics
15.3.5. Personalized Medicine
15.3.6. Others
15.4. Market Value Forecast By Indication, 2020-2034
15.4.1. Oncological Disorders
15.4.2. Cardiovascular Disorders
15.4.3. Neurological Disorders
15.4.4. Metabolic Disorders
15.4.5. Others
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Academic and Research Institutes
15.5.2. Pharmaceutical and Biotechnology Companies
15.5.3. Contract Research Organizations
15.6. Market Value Forecast By Country / Sub-region, 2020-2034
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product and Service Type
15.7.2. By Application
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country / Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Waters Corporation
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Agilent Technologies, Inc.
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. Thermo Fisher Scientific Inc.
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. Danaher Corporation
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. Bruker Corporation
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. PerkinElmer
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. Merck KGaA
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments
16.2.8. Metabolon, Inc.
16.2.8.1. Company Overview
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Business Strategies
16.2.8.5. Recent Developments
16.2.9. Afekta Technologies Ltd.
16.2.9.1. Company Overview
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Business Strategies
16.2.9.5. Recent Developments
16.2.10. Shimadzu Corporation
16.2.10.1. Company Overview
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Business Strategies
16.2.10.5. Recent Developments

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings